{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T05:10:18Z","timestamp":1741756218675,"version":"3.38.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,11]]},"DOI":"10.7759\/cureus.80440","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:30:33Z","timestamp":1741753833000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Serum Sestrin 2 Levels in Women With Polycystic Ovary Syndrome: A Single-Center Cross-Sectional Case-Control Study"],"prefix":"10.7759","author":[{"given":"Lohit","family":"Kumbar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramila","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanumantha Rao","family":"Maddukuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55439","article-title":"BMI and polycystic ovary syndrome: demographic trends in weight and health","volume":"16","author":"Mohapatra I","year":"2024","unstructured":"Mohapatra I, Samantaray SR. BMI and polycystic ovary syndrome: demographic trends in weight and health. Cureus. 2024, 16:e55439. 10.7759\/cureus.55439","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.40583","article-title":"Prevalence, phenotypes, and comorbidities of polycystic ovary syndrome among Indian women","volume":"7","author":"Ganie MA","year":"2024","unstructured":"Ganie MA, Chowdhury S, Malhotra N, et al.. Prevalence, phenotypes, and comorbidities of polycystic ovary syndrome among Indian women. JAMA Netw Open. 2024, 7:e2440583. 10.1001\/jamanetworkopen.2024.40583","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13061113","article-title":"Current guidelines for diagnosing PCOS","volume":"13","author":"Christ JP","year":"2023","unstructured":"Christ JP, Cedars MI. Current guidelines for diagnosing PCOS. Diagnostics (Basel). 2023, 13:1113. 10.3390\/diagnostics13061113","journal-title":"Diagnostics (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0523-8","article-title":"New markers of insulin resistance in polycystic ovary syndrome","volume":"40","author":"Polak K","year":"2017","unstructured":"Polak K, Czyzyk A, Simoncini T, Meczekalski B. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest. 2017, 40:1-8. 10.1007\/s40618-016-0523-8","journal-title":"J Endocrinol Invest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23957","article-title":"Sestrin2 and Beclin1 levels in polycystic ovary syndrome","volume":"35","author":"Saeedi V","year":"2021","unstructured":"Saeedi V, Nourbakhsh M, Nourbakhsh M, Haghighi L, Kamalzadeh L, Ezzati Mobasser S, Razzaghy-Azar M. Sestrin2 and Beclin1 levels in polycystic ovary syndrome. J Clin Lab Anal. 2021, 35:e23957. 10.1002\/jcla.23957","journal-title":"J Clin Lab Anal"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10025","article-title":"Janus-faced sestrin2 controls ROS and mTOR signalling through two separate functional domains","volume":"6","author":"Kim H","year":"2015","unstructured":"Kim H, An S, Ro SH, et al.. Janus-faced sestrin2 controls ROS and mTOR signalling through two separate functional domains. Nat Commun. 2015, 6:10025. 10.1038\/ncomms10025","journal-title":"Nat Commun"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.08.004","article-title":"Maintenance of metabolic homeostasis by sestrin2 and sestrin3","volume":"16","author":"Lee JH","year":"2012","unstructured":"Lee JH, Budanov AV, Talukdar S, et al.. Maintenance of metabolic homeostasis by sestrin2 and sestrin3. Cell Metab. 2012, 16:311-21. 10.1016\/j.cmet.2012.08.004","journal-title":"Cell Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1089\/chi.2017.0082","article-title":"Evaluation of plasma TRB3 and sestrin 2 levels in obese and normal-weight children","volume":"13","author":"Nourbakhsh M","year":"2017","unstructured":"Nourbakhsh M, Sharifi R, Ghorbanhosseini SS, Javad A, Ahmadpour F, Razzaghy Azar M, Larijani B. Evaluation of plasma TRB3 and sestrin 2 levels in obese and normal-weight children. Child Obes. 2017, 13:409-14. 10.1089\/chi.2017.0082","journal-title":"Child Obes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ajum.12096","article-title":"Rotterdam criteria, the end","volume":"21","author":"Smet ME","year":"2018","unstructured":"Smet ME, McLennan A. Rotterdam criteria, the end. Australas J Ultrasound Med. 2018, 21:59-60. 10.1002\/ajum.12096","journal-title":"Australas J Ultrasound Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.07.024","article-title":"Association of serum sestrin2 level with metabolic risk factors in newly diagnosed drug-na\u00efve type 2 diabetes","volume":"144","author":"Chung HS","year":"2018","unstructured":"Chung HS, Hwang HJ, Hwang SY, et al.. Association of serum sestrin2 level with metabolic risk factors in newly diagnosed drug-na\u00efve type 2 diabetes. Diabetes Res Clin Pract. 2018, 144:34-41. 10.1016\/j.diabres.2018.07.024","journal-title":"Diabetes Res Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1085656","article-title":"Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome","volume":"13","author":"Zhang H","year":"2022","unstructured":"Zhang H, Wang W, Zhao J, et al.. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2022, 13:1085656. 10.3389\/fendo.2022.1085656","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-80238-z","article-title":"The association between dietary obesity-prevention score (DOS) and polycystic ovary syndrome: a case-control study","volume":"14","author":"Mahabady M","year":"2024","unstructured":"Mahabady M, Zolfaghari H, Samimi M, Gilasi H, Sharifi N, Aminianfar A. The association between dietary obesity-prevention score (DOS) and polycystic ovary syndrome: a case-control study. Sci Rep. 2024, 14:28618. 10.1038\/s41598-024-80238-z","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4274\/BMB.galenos.2020.03.07","article-title":"Polycystic ovary syndrome in overweight and normal weight women: the relationships with inflammatory markers","volume":"5","author":"Atakul T","year":"2020","unstructured":"Atakul T, Turan \u00d6D, Yenisey \u00c7. Polycystic ovary syndrome in overweight and normal weight women: the relationships with inflammatory markers. Bagcilar Med Bull. 2020, 5:45-51. 10.4274\/BMB.galenos.2020.03.07","journal-title":"Bagcilar Med Bull"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20213","article-title":"Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women","volume":"21","author":"Teede HJ","year":"2013","unstructured":"Teede HJ, Joham AE, Paul E, Moran LJ, Loxton D, Jolley D, Lombard C. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity (Silver Spring). 2013, 21:1526-32. 10.1002\/oby.20213","journal-title":"Obesity (Silver Spring)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/nu15163652","article-title":"Abdominal obesity in women with polycystic ovary syndrome and its relationship with diet, physical activity and insulin resistance: a pilot study","volume":"15","author":"Jurczewska J","year":"2023","unstructured":"Jurczewska J, Ostrowska J, Che\u0142chowska M, et al.. Abdominal obesity in women with polycystic ovary syndrome and its relationship with diet, physical activity and insulin resistance: a pilot study. Nutrients. 2023, 15:3652. 10.3390\/nu15163652","journal-title":"Nutrients"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtumed.2016.11.005","article-title":"Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome","volume":"12","author":"Chitme HR","year":"2017","unstructured":"Chitme HR, Al Azawi EA, Al Abri AM, Al Busaidi BM, Salam ZK, Al Taie MM, Al Harbo SK. Anthropometric and body composition analysis of infertile women with polycystic ovary syndrome. J Taibah Univ Med Sci. 2017, 12:139-45. 10.1016\/j.jtumed.2016.11.005","journal-title":"J Taibah Univ Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-021-00710-z","article-title":"Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with polycystic ovarian syndrome (PCOS)","volume":"21","author":"Shirazi FK","year":"2021","unstructured":"Shirazi FK, Khodamoradi Z, Jeddi M. Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with polycystic ovarian syndrome (PCOS). BMC Endocr Disord. 2021, 21:45. 10.1186\/s12902-021-00710-z","journal-title":"BMC Endocr Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.55730\/1300-0144.5738","article-title":"Evaluation of sestrin 2 and tribbles homolog 3 levels in obese and nonobese women with polycystic ovary syndrome","volume":"53","author":"\u00c7atal A","year":"2023","unstructured":"\u00c7atal A, Kovalak EE. Evaluation of sestrin 2 and tribbles homolog 3 levels in obese and nonobese women with polycystic ovary syndrome. Turk J Med Sci. 2023, 53:1697-703. 10.55730\/1300-0144.5738","journal-title":"Turk J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02797","article-title":"Sestrin2: its potential role and regulatory mechanism in host immune response in diseases","volume":"10","author":"Wang LX","year":"2019","unstructured":"Wang LX, Zhu XM, Yao YM. Sestrin2: its potential role and regulatory mechanism in host immune response in diseases. Front Immunol. 2019, 10:2797. 10.3389\/fimmu.2019.02797","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101186","article-title":"Protective response of sestrin under stressful conditions in aging","volume":"64","author":"Rai N","year":"2020","unstructured":"Rai N, Dey S. Protective response of sestrin under stressful conditions in aging. Ageing Res Rev. 2020, 64:101186. 10.1016\/j.arr.2020.101186","journal-title":"Ageing Res Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.04.084","article-title":"Increased plasma sestrin2 concentrations in patients with chronic heart failure and predicted the occurrence of major adverse cardiac events: a 36-month follow-up cohort study","volume":"495","author":"Wang H","year":"2019","unstructured":"Wang H, Li N, Shao X, et al.. Increased plasma sestrin2 concentrations in patients with chronic heart failure and predicted the occurrence of major adverse cardiac events: a 36-month follow-up cohort study. Clin Chim Acta. 2019, 495:338-44. 10.1016\/j.cca.2019.04.084","journal-title":"Clin Chim Acta"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1089\/met.2020.0018","article-title":"Diagnostic value of sestrin2 in patients with obstructive sleep apnea","volume":"18","author":"Chai J","year":"2020","unstructured":"Chai J, Wang J, Jiang R, et al.. Diagnostic value of sestrin2 in patients with obstructive sleep apnea. Metab Syndr Relat Disord. 2020, 18:362-7. 10.1089\/met.2020.0018","journal-title":"Metab Syndr Relat Disord"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-019-0360-3","article-title":"Sestrin2 is involved in asthma: a case-control study","volume":"15","author":"Kang Y","year":"2019","unstructured":"Kang Y, Chen C, Hu X, et al.. Sestrin2 is involved in asthma: a case-control study. Allergy Asthma Clin Immunol. 2019, 15:46. 10.1186\/s13223-019-0360-3","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.12204","article-title":"Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis","volume":"5","author":"Ro SH","year":"2016","unstructured":"Ro SH, Xue X, Ramakrishnan SK, et al.. Tumor suppressive role of sestrin2 during colitis and colon carcinogenesis. Elife. 2016, 5:e12204. 10.7554\/eLife.12204","journal-title":"Elife"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2016.02.002","article-title":"Sestrin-2 is significantly increased in malignant pleural effusions due to lung cancer and is potentially secreted by pleural mesothelial cells","volume":"49","author":"Tsilioni I","year":"2016","unstructured":"Tsilioni I, Filippidis AS, Kerenidi T, Budanov AV, Zarogiannis SG, Gourgoulianis KI. Sestrin-2 is significantly increased in malignant pleural effusions due to lung cancer and is potentially secreted by pleural mesothelial cells. Clin Biochem. 2016, 49:726-8. 10.1016\/j.clinbiochem.2016.02.002","journal-title":"Clin Biochem"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glz234","article-title":"Sestrin2 as serum protein marker and potential therapeutic target for Parkinson\u2019s disease","volume":"75","author":"Rai N","year":"2020","unstructured":"Rai N, Upadhyay AD, Goyal V, Dwivedi S, Dey AB, Dey S. Sestrin2 as serum protein marker and potential therapeutic target for Parkinson\u2019s disease. J Gerontol A Biol Sci Med Sci. 2020, 75:690-5. 10.1093\/gerona\/glz234","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/1533317519848234","article-title":"Prevalence of dementia among older patients: a hospital-based study in Iran","volume":"34","author":"Kamalzadeh L","year":"2019","unstructured":"Kamalzadeh L, Moghaddamnia M, Malakouti SK, et al.. Prevalence of dementia among older patients: a hospital-based study in Iran. Am J Alzheimers Dis Other Demen. 2019, 34:500-6. 10.1177\/1533317519848234","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2022-0315","article-title":"The relationship between hormonal levels and hematological parameters in cystic ovarian syndrome","volume":"16","author":"Al Kafhage FA","year":"2023","unstructured":"Al Kafhage FA, Abbas AN, Al-Masaoodi RA, Hassan S, Al-Shemery MK. The relationship between hormonal levels and hematological parameters in cystic ovarian syndrome. J Med Life. 2023, 16:937-40. 10.25122\/jml-2022-0315","journal-title":"J Med Life"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2022.2163234","article-title":"Could sestrin protein in serum be a new marker of oxidative stress in\u00a0patients with polycystic ovary syndrome?","volume":"38","author":"Bestel A","year":"2022","unstructured":"Bestel A, Elmas B, G\u00fcnkaya OS, Bestel M, Bahat PY. Could sestrin protein in serum be a new marker of oxidative stress in\u00a0patients with polycystic ovary syndrome?. Gynecol Endocrinol. 2022, 38:1109-13. 10.1080\/09513590.2022.2163234","journal-title":"Gynecol Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348918-assessment-of-serum-sestrin-2-levels-in-women-with-polycystic-ovary-syndrome-a-single-center-cross-sectional-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:30:35Z","timestamp":1741753835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348918-assessment-of-serum-sestrin-2-levels-in-women-with-polycystic-ovary-syndrome-a-single-center-cross-sectional-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.80440","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,11]]}}}